Make your money go further for just 25p per day

Tristel (AIM: TSTL) – brilliant results and all is looking good

25/02/2015 · Tristel (TSTL) 

The manufacturer of infection prevention, contamination control and hygiene products has announced terrific interim results for the six months ended 31 December 2014.

Revenue was up 15% to £7.4m including international sales up 26% to £2.4m, pre-tax profit before share based payments up 57% to £1.1m and basic EPS up 85% to 1.91p. 

The Group finished the period with net cash of £2.9m (2013: £1.5m)

Tristel’s lead technology is a proprietary Chlorine dioxide formulation addressing three distinct markets:

- The Human Healthcare market (hospital infection prevention - via the Tristel brand)
- The Contamination Control market (control of contamination in critical environments - via the Crystel brand)
- The Animal Healthcare market (veterinary practice infection prevention - via the Anistel brand)

The significant capital investment over the past few years, including £400,000 in creating 20,000 sq ft of new factory, office and warehouse space which was officially opened on 2nd October 2014 puts the business in great shape to support further growth. 

The Group’s proprietary technology that is supported by widespread patent protection covering two-thirds of…

Sign up and read the full article

Register to continue reading this article.

Get FREE access now

Already a member? Login

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world


Become a Champion Investor for as little as £3.20 per report or get a year's worth of money-making analysis for just £90.


More on Tristel

Portfolio Flash News: April

30/04/2019 · Portfolio Flash News

It’s not always easy to keep track of your investments. Sometimes big news gets hidden in…

Investor’s Champion podcast: ISA time

03/04/2019 · Podcasts
It’s ISA time. With just two days to go before the ISA deadline, it’s a good…

Tristel gains key approval in China

01/04/2019 · Portfolio Flash News
Tristel has its sights firmly set on China as a crucial market for long-term revenue growth.…

Tristel looks to China for more growth

13/03/2019 · Portfolio

The value of Tristel’s medical device decontamination products are highlighted by the fact that the company…

6 quality AIM shares for your portfolio

15/10/2015 · News & Insights
Our Blog this week has featured results and updates from a number of wonderful small…

More from the News & Insights

Sports Direct struggles to manage Goals

Premier Technical Services 140% premium - who missed out?

Video games developer Team17 continues to impress

18/06/2019 · Team17 Group PLC